1. Home
  2. RCEL vs FRGE Comparison

RCEL vs FRGE Comparison

Compare RCEL & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • FRGE
  • Stock Information
  • Founded
  • RCEL N/A
  • FRGE 2014
  • Country
  • RCEL United States
  • FRGE United States
  • Employees
  • RCEL 260
  • FRGE N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • FRGE Computer Software: Prepackaged Software
  • Sector
  • RCEL Health Care
  • FRGE Technology
  • Exchange
  • RCEL Nasdaq
  • FRGE Nasdaq
  • Market Cap
  • RCEL 136.7M
  • FRGE 175.1M
  • IPO Year
  • RCEL N/A
  • FRGE N/A
  • Fundamental
  • Price
  • RCEL $5.71
  • FRGE $16.77
  • Analyst Decision
  • RCEL Strong Buy
  • FRGE Buy
  • Analyst Count
  • RCEL 4
  • FRGE 5
  • Target Price
  • RCEL $16.50
  • FRGE $38.25
  • AVG Volume (30 Days)
  • RCEL 308.7K
  • FRGE 108.0K
  • Earning Date
  • RCEL 08-07-2025
  • FRGE 08-06-2025
  • Dividend Yield
  • RCEL N/A
  • FRGE N/A
  • EPS Growth
  • RCEL N/A
  • FRGE N/A
  • EPS
  • RCEL N/A
  • FRGE N/A
  • Revenue
  • RCEL $71,661,000.00
  • FRGE $85,383,000.00
  • Revenue This Year
  • RCEL $57.16
  • FRGE $18.22
  • Revenue Next Year
  • RCEL $36.69
  • FRGE $29.35
  • P/E Ratio
  • RCEL N/A
  • FRGE N/A
  • Revenue Growth
  • RCEL 41.35
  • FRGE 16.04
  • 52 Week Low
  • RCEL $4.71
  • FRGE $6.60
  • 52 Week High
  • RCEL $14.16
  • FRGE $24.45
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 49.89
  • FRGE 48.69
  • Support Level
  • RCEL $5.13
  • FRGE $17.48
  • Resistance Level
  • RCEL $5.87
  • FRGE $19.94
  • Average True Range (ATR)
  • RCEL 0.31
  • FRGE 0.96
  • MACD
  • RCEL 0.14
  • FRGE -0.30
  • Stochastic Oscillator
  • RCEL 83.19
  • FRGE 12.03

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About FRGE Forge Global Holdings Inc.

Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.

Share on Social Networks: